BLOG

Tessera Therapeutics: addressing Alpha-1 Antitrypsin Deficiency

At Tessera, we are building a broad toolkit of Gene Writers™ to therapeutically edit the genome. Our RNA Gene Writers are designed to efficiently introduce a range of genomic changes from small nucleotide substitutions to exon or gene-sized fragments using all‑RNA compositions.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}